Statin-associated adverse cognitive effects: survey results from 171 patients. - Wikidata - awgldk - TriplyDB

Statin-associated adverse cognitive effects: survey results from 171 patients.

Statin-associated adverse cognitive effects: survey results from 171 patients.

http://www.wikidata.org/entity/Q46011754

about

Statins for the prevention of dementia Statins, cognition, and dementia—systematic review and methodological commentary How do we improve patient compliance and adherence to long-term statin therapy?Cholesterol, statins, and dementia: what the cardiologist should know Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Development and Content Validity of the Statin Experience Assessment Questionnaire (SEAQ)©.Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection.Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study Long-term atorvastatin treatment leads to alterations in behavior, cognition, and hippocampal biochemistry.Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors Statin Therapy and Risk of Acute Memory Impairment.The effects of cholesterol on learning and memory.Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations.A cell-based fascin bioassay identifies compounds with potential anti-metastasis or cognition-enhancing functions.Guiding principles for the care of older adults with multimorbidity: an approach for clinicians: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity.Associations between disease awareness and health-related quality of life in a multi-ethnic Asian population.Chronic pravastatin but not atorvastatin treatment impairs cognitive function in two rodent models of learning and memory Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention Diabetes and insulin in regulation of brain cholesterol metabolism A review of the potential therapeutic role of statins in the treatment of Alzheimer's disease: current research and opinion.Simvastatin-induced cognitive dysfunction: two case reports Psychologic disorders and statin use: a propensity score-matched analysis Effect of preoperative statin therapy on early postoperative memory impairment after off-pump coronary artery bypass surgery.Mood, Personality, and Behavior Changes During Treatment with Statins: A Case Series Physicians' Experiences as Patients with Statin Side Effects: A Case Series Event reduction: revisiting why we treat with statins and harnessing current evidence towards optimal therapy.The controversy of a wider statin utilization: why?Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.Cognitive effects of statin medications.The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.An update on the benefits and risks of rosuvastatin therapy.Addressing statin adverse effects in the clinic: the 5 Ms.Aggressive lipid management in very elderly adults: less is more.How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease.Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Management of acute ischaemic stroke in patients with dementia.

P2860

Q24186591-3DD1C550-FA62-4B68-BB48-19ED0F8E92FD Q26852778-7BC70BE0-807C-4087-ACC7-7F8DA8324FF5 Q27691392-5F1CEFEE-13E7-4099-A4E0-1FAB191F003D Q28081974-7500757E-8D23-4A9D-B9E1-17286C72462C Q28085282-DCD51601-7AD4-462C-BAA6-E01E8CE82542 Q30814231-255BAD32-AA5B-4C5A-898E-CD8F555CA256 Q30848030-97F63901-A104-4037-AC0D-70508DC4021D Q31105715-BEC83213-068A-48DB-BF8D-5C0EF86EB1CA Q33623532-FF8958E9-92A7-424E-B28A-2933135BCDC5 Q33647341-4C7DC3AA-0063-4D66-867E-88684D301177 Q33761463-E64C96A1-E6F6-49D6-98F5-856F801AEB55 Q33763342-EDC316CE-E89E-4EEA-8E79-FB48AE15B680 Q33844336-0D11D043-80AE-4AB0-BBC9-D7086B95C8FA Q33976829-1130108C-5780-42ED-AB7F-390BAEDE6011 Q34219598-8FB03BAE-C9C6-4E10-B67B-8258EC58F0D7 Q34392217-13CBC4E3-932E-46B6-BE26-88B6F88D3515 Q34418562-9744746F-4E29-444F-A724-4B67232B68DD Q34576516-F1E25A37-19B1-4812-9F1F-032FDF34E877 Q34990621-14B9B626-0303-4FA7-857B-FB9A7BD7F0CB Q35004412-9FF080C7-DA88-4A19-AEF9-EDED4305005C Q35499561-DE9EEE0A-89A3-46D1-89D3-AD2E24676118 Q36520625-CA2DFFC5-A0EB-498C-9B1F-1B6BEE21B3FE Q36769580-5680D561-C9CF-45F9-9E1A-30ACE44264A4 Q36913817-CD343C46-BDD3-480D-9C32-C248180A25F8 Q36988012-2C376EBE-1578-4FFF-93B3-56D654FDEBF1 Q37218787-7BCDD05A-94D8-4D53-B07B-CE3CECB840BF Q37651630-91BE1AC0-318A-4206-AF6F-044D5290DC87 Q37812387-7E22A628-78C9-4D58-8EA3-188C9C016C6C Q38089090-021DF57C-83C7-4492-A34F-31F44ACAFAF9 Q38109095-77FC74AF-F2EF-45C4-BDD8-61F1B5DCB79F Q38113494-2A5D8F4D-90E7-4AF8-9F39-600B60EC181F Q38179262-C605F197-1E45-4F89-8355-6676668F2279 Q38185988-F10E542E-234B-414F-8C87-A256FF95FFE4 Q38191275-B98B219F-5A89-4669-B93D-825588DDB980 Q38200826-526FDE16-DA9F-40BA-BD22-E42FF3926F3A Q38207488-A194E4B9-2023-493A-BE98-B212838B5788 Q38209732-A27B5E7D-DB6A-4347-A415-C12CF1FA3F12 Q38352155-C7B3604C-A213-47DF-9B19-32D84FE7E39E Q38414035-2874742C-058C-4EFA-A34A-45E93787C77C Q38763038-42FF60DC-74DF-4319-9214-0AB43D86AEA7

P2860

Statin-associated adverse cognitive effects: survey results from 171 patients.

http://www.wikidata.org/entity/Q46011754

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Statin-associated adverse cognitive effects: survey results from 171 patients.

@en

Statin-associated adverse cognitive effects: survey results from 171 patients.

@nl

type

label

Statin-associated adverse cognitive effects: survey results from 171 patients.

@en

Statin-associated adverse cognitive effects: survey results from 171 patients.

@nl

prefLabel

Statin-associated adverse cognitive effects: survey results from 171 patients.

@en

Statin-associated adverse cognitive effects: survey results from 171 patients.

@nl

P1433

Q46011754-AC7DCA4D-EB8C-4034-BC2D-8E9F874EC187

P1476

Q46011754-57E065B9-3184-44B3-B09B-9C9F32BC952D

P2093

Q46011754-A6BD3D47-FFCA-43CF-A652-D0F52557F8A7

Q46011754-E1E4CFC9-3751-4F00-B5B9-5608B793667E

P2860

Q46011754-02DFCFB0-EAC9-4EB9-94B1-7A81A77D7415

Q46011754-11DCB89C-8697-4E7A-B8A2-7353CB38CA79

Q46011754-15758873-FAEC-4AEE-9924-42EFEF993E97

Q46011754-15C6CA55-5846-437C-B992-98964D54BB37

Q46011754-19611286-BDC6-4270-8C9F-7E203EA7CF87

Q46011754-1B2B47E1-BC84-4AC2-8327-5F0EBA615D75

Q46011754-205968E0-085F-44CF-9549-FB93546FE9FF

Q46011754-283C66DA-7CC2-4036-97A9-0D3F403C0148

Q46011754-4922DFE7-723D-43B4-A8AC-0EAFAA5030D4

Q46011754-4D700F4F-6ACA-4808-AEAC-31276328B479

P304

Q46011754-AEA50AFE-F424-4321-9D0A-A46EA635DB20

P31

Q46011754-7BBAF5D3-87B9-433B-8B1D-1A6CA8A2CB90

P356

Q46011754-0B772B1F-B685-44B9-B363-05B3CCC513E3

P407

Q46011754-57A99307-20EF-4B7D-A136-67D3C342138F

P433

Q46011754-05A74A96-EDCD-4715-80B3-33109AB2CD9D

P478

Q46011754-C20841F0-5A31-4837-B551-966527773AA7

P577

Q46011754-CCCB4DFD-825D-4382-AFC6-98F9D88393E4

P698

Q46011754-C4A008CB-608A-4C00-AD60-D92C34C81190

P921

Q46011754-40F8381F-1513-4514-B64F-C3A246D246F6

P356

P1433

Pharmacotherapy

P1476

Statin-associated adverse cognitive effects: survey results from 171 patients.

@en

P2093

Beatrice A Golomb

http://www.w3.org/2001/XMLSchema#string

Marcella A Evans

http://www.w3.org/2001/XMLSchema#string

P2860

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Timing of new black box warnings and withdrawals for prescription medications

Peripheral neuropathy associated with simvastatin.

A method for estimating the probability of adverse drug reactions

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

SLCO1B1 variants and statin-induced myopathy--a genomewide study

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Effects of lovastatin on cognitive function and psychological well-being.

P304

800-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.29.7.800

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19558254

http://www.w3.org/2001/XMLSchema#string

P921